Alain Ravaud

Phase 3 trial of everolimus for metastatic renal cell carcinoma

Norbert Hollaender, C. Porta, A. Ravaud, 2010, Cancer.

First-line everolimus followed by second-line sunitinib versus the opposite treatment sequence in patients with metastatic renal cell carcinoma (mRCC).

Nicolas Rouyrre, Jennifer J. Knox, A. Ravaud, 2010 .

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

Bohuslav Melichar, A. Ravaud, B. Melichar, 2007, The Lancet.

Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: a randomized phase III clinical trial.

Frank Pétavy, Jean-Pascal Machiels, Patrick Schöffski, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal‐Cell Carcinoma

Bohuslav Melichar, Yoshihiko Tomita, Nizar M. Tannir, 2018, The New England journal of medicine.

Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study.

Chris Twelves, A. Ravaud, J. Wanders, 2005, European journal of cancer.